Drug Type TCR therapy |
Synonyms- |
Target |
Mechanism AFP inhibitors(Alpha-fetoprotein inhibitors), IL-21R inhibitors(Interleukin 21 Receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | CN | 20 Apr 2024 |